4.7 Article

High cytotoxic sensitivity of the oligodendrocyte precursor cells to HSP90 inhibitors in cell cultures

期刊

EXPERIMENTAL NEUROLOGY
卷 216, 期 2, 页码 511-514

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2008.12.022

关键词

Heat shock protein 90; HSP90 inhibitors; Geldanamycin; 17-allylamino-17-demethoxygeldanamycin; Radicicol; Oligodendrocyte precursor cells; O-2A cells; Cell death

资金

  1. ISCIII [0810761]
  2. Spanish Ministry of Science and Innovation [RETICS-RD06/0026/0008, CFM2008-00304]

向作者/读者索取更多资源

Oligodendrocyte precursor cells (OPCs) are able to proliferate, and most differentiate into post-mitotic oligodendrocytes that contribute to remyelination. We have previously studied the expression of heat shock protein90 (HSP90) in OPCs. The ansamycins, such as geldanamycin and 17-allylamino-17-demethoxygeldanamycin (17-AAG) act as specific HSP90 inhibitors, are potent anti-tumor agents and are currently undergoing clinical trials. This work investigated the effect of HSP90 inhibitors on cultured OPCs. Geldanamycin, 17-AAG and another chernically unrelated HSP90 inhibitor, radicicol, were extremely cytotoxic for OPCs. The IC50 values of geldanamycin, 17-AAG and radicicol for OPCs were 7.1,10.7 and 137 nM, respectively, compared to 1000-2000 nM for preoligodendrocytes, astrocytes and neurons. AdultOPCs were found to be susceptible to HSP90 inhibitors in a similar fashion to perinatal cells. OPC death induced by these HSP90 inhibitors led to a significant decrease in the oligodendrocyte population. The present results highlight that OPCs are uniquely sensitive to HSP90 inhibitors. Geldanamycin and 17-AAG, which penetrate the blood-brain barrier, are novel cancer chemotherapeutic agents and we noted that, in anti-cancer therapy with these drugs, the OPCs may be compromised. (C) 2009 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据